Publicacións nas que colabora con Maria Bryszewska (65)

2024

  1. A new class of polyphenolic carbosilane dendrimers binds human serum albumin in a structure-dependent fashion

    Scientific Reports, Vol. 14, Núm. 1

  2. Effect of polyphenolic dendrimers on biological and artificial lipid membranes

    Chemistry and Physics of Lipids, Vol. 265

  3. Polyphenolic dendrimers as carriers of anticancer siRNA

    International Journal of Pharmaceutics, Vol. 658

  4. Synthesis and biophysical evaluation of carbosilane dendrimers as therapeutic siRNA carriers

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study

    International Journal of Pharmaceutics, Vol. 636

  2. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  3. Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols

    Colloids and Surfaces B: Biointerfaces, Vol. 227

  4. Pegylated Gold Nanoparticles Conjugated with siRNA: Complexes Formation and Cytotoxicity

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  5. Ruthenium metallodendrimer against triple-negative breast cancer in mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 53

2022

  1. Heterofunctionalized polyphenolic dendrimers decorated with caffeic acid: Synthesis, characterization and antioxidant activity

    Sustainable Materials and Technologies, Vol. 33

  2. Interaction of Cationic Carbosilane Dendrimers and Their siRNA Complexes with MCF-7 Cells Cultured in 3D Spheroids

    Cells, Vol. 11, Núm. 10

  3. The effect of surface modification of dendronized gold nanoparticles on activation and release of pyroptosis-inducing pro-inflammatory cytokines in presence of bacterial lipopolysaccharide in monocytes

    Colloids and Surfaces B: Biointerfaces, Vol. 217

2021

  1. Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons

    Biomacromolecules, Vol. 22, Núm. 11, pp. 4582-4591

  2. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

    Dalton Transactions, Vol. 50, Núm. 27, pp. 9500-9511

  3. Comparison of the effects of dendrimer, micelle and silver nanoparticles on phospholipase A2 structure

    Journal of Biotechnology, Vol. 331, pp. 48-52

  4. Dendronized Gold Nanoparticles as Carriers for gp160 (HIV-1) Peptides: Biophysical Insight into Complex Formation

    Langmuir, Vol. 37, Núm. 4, pp. 1542-1550

  5. Evaluation of dendronized gold nanoparticles as siRNAs carriers into cancer cells

    Journal of Molecular Liquids, Vol. 324

  6. Interaction of cationic carbosilane dendrimers and their siRNA complexes with MCF-7 cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

  7. Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA

    Journal of Inorganic Biochemistry, Vol. 223

  8. PEGylation of Dendronized Gold Nanoparticles Affects Their Interaction with Thrombin and siRNA

    Journal of Physical Chemistry B, Vol. 125, Núm. 4, pp. 1196-1206